CompletedNCT00774085
Long-acting injectable risperidone treatment and outcomes in schizophrenia
About this title
Read the official source — NCT00774085Observational study
Understand this study
Study information
Study start dateNovember 2004
- Recruitment status
- Completed
- Enrollment listed in the registry
- 408
- Sponsor
- Janssen Cilag N.V./S.A.
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- OTHER
- Study phase
- Not clearly listed
- Locations
- Not clearly listed
- Age range
- Not clearly listed
- Official registry ID
- NCT00774085
- Official title
Show the full official title
Electronic Schizophrenia Treatment Adherence Registry
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedLocations not listed
Questions about this study
Who is behind this study?
The study sponsor is Janssen Cilag N.V./S.A.
